Evidence map›Paper›PMID 28035010›Full record

Observational studyThe Journal of infectious diseases2017

Association of Pneumococcal Protein Antigen Serology With Age and Antigenic Profile of Colonizing Isolates.

Taj Azarian, Lindsay R Grant, Maria Georgieva, Laura L Hammitt, Raymond Reid, Stephen D Bentley, David Goldblatt, Mathuran Santosham, Robert Weatherholtz, Paula Burbidge and 5 more

Open access · bronzeAbstract readObservational Study
In one paragraph

Observational study in The Journal of infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. [Dose-response relationship between age andZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2023
    Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Evolution ofGenes · 2019
    Article
  9. Review
  10. Article
  11. Observational
  12. Article
  13. Frontiers in immunology · 2018
    Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Taj AzarianCenter for Communicable Disease Dynamics, Department of Epidemiology, T. H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA.
Lindsay R GrantCenter for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Maria GeorgievaCenter for Communicable Disease Dynamics, Department of Epidemiology, T. H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA.
Laura L HammittCenter for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Raymond ReidCenter for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Stephen D BentleyWellcome Trust Sanger Institute, Cambridge, Hinxton, UK.
David GoldblattImmunobiology Section, Institute of Child Health, University College London, UK.
Mathuran SantoshamCenter for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Robert WeatherholtzCenter for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Paula BurbidgeImmunobiology Section, Institute of Child Health, University College London, UK.
Novalene GoklishCenter for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Claudette M ThompsonCenter for Communicable Disease Dynamics, Department of Epidemiology, T. H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA.
William P HanageCenter for Communicable Disease Dynamics, Department of Epidemiology, T. H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA.
Kate L O'BrienCenter for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Marc LipsitchCenter for Communicable Disease Dynamics, Department of Epidemiology, T. H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA.
Johns Hopkins University · USCenter for Disease Dynamics, Economics & Policy · USHarvard University · USUniversity College London · GBWellcome Sanger Institute · GB

Funding

VACCINATION AND THE EVOLUTIONARY DYNAMICS OF PNEUMOCOCCIR01AI048935 · NIAID · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI LIPSITCH, MARC · 2001 to 2016
$8.8M
Ecological and genetic contributions to the spread of resistance in pneumococcusR01AI106786 · NIAID · HARVARD SCHOOL OF PUBLIC HEALTH · PI HANAGE, WILLIAM · 2013 to 2017
$3.1M
NIAID NIH HHS R01 AI048935NIAID NIH HHS R01 AI106786
6 · The paper itself

Abstract

Background: Several Streptococcus pneumoniae proteins play a role in pathogenesis and are being investigated as vaccine targets. It is largely unknown whether naturally acquired antibodies reduce the risk of colonization with strains expressing a particular antigenic variant. Methods: Serum immunoglobulin G (IgG) titers to 28 pneumococcal protein antigens were measured among 242 individuals aged <6 months-78 years in Native American communities between 2007 and 2009. Nasopharyngeal swabs were collected >- 30 days after serum collection, and the antigen variant in each pneumococcal isolate was determined using genomic data. We assessed the association between preexisting variant-specific antibody titers and subsequent carriage of pneumococcus expressing a particular antigen variant. Results: Antibody titers often increased across pediatric groups before decreasing among adults. Individuals with low titers against group 3 pneumococcal surface protein C (PspC) variants were more likely to be colonized with pneumococci expressing those variants. For other antigens, variant-specific IgG titers do not predict colonization. Conclusion: We observed an inverse association between variant-specific antibody concentration and homologous pneumococcal colonization for only 1 protein. Further assessment of antibody repertoires may elucidate the nature of antipneumococcal antibody-mediated mucosal immunity while informing vaccine development.

Indexed as

Age FactorsAdolescentAdultAgedAntibodies, BacterialAntigens, BacterialBacterial ProteinsCarrier StateChildChild, PreschoolFollow-Up StudiesHeat-Shock ProteinsHumansImmunoglobulin GInfantLogistic ModelsAntibodies, BacterialAntigens, BacterialBacterial ProteinsHeat-Shock ProteinsImmunoglobulin Gphage shock protein, BacteriaSpsA protein, Streptococcus pneumoniaeantibodyimmunologypiluspneumococciprotein antigensPspAPspCseraStreptococcus pneumoniaevaccine

Identifiers

PMID28035010
PMCPMC6005115
OpenAlexW2562816963

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.